{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:57:07Z","timestamp":1788245827202,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences","award":["2019-I2M-5-066"],"award-info":[{"award-number":["2019-I2M-5-066"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82371818; 82161138022; 82030003"],"award-info":[{"award-number":["82371818; 82161138022; 82030003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1136\/ard-2024-225596","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T13:15:12Z","timestamp":1714396512000},"page":"1144-1155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Identification and validation of anti-protein arginine methyltransferase 5 (PRMT5) antibody as a novel biomarker for systemic sclerosis (SSc)"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7650-1237","authenticated-orcid":false,"given":"Minrui","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingbiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8634-0967","authenticated-orcid":false,"given":"Liwei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2765-0620","authenticated-orcid":false,"given":"Jiucun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hejian","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianlei","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard-2024-225596_bib1","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1136\/ard-2024-225596_bib2","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"10.1136\/ard-2024-225596_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/exd.14193","article-title":"Cellular and molecular mechanisms in fibrosis","volume":"30","author":"Dees","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1136\/ard-2024-225596_bib4","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41584-019-0322-7","article-title":"Shared and distinct mechanisms of fibrosis","volume":"15","author":"Distler","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/ard-2024-225596_bib5","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.autrev.2012.05.011","article-title":"Autoantibodies in systemic sclerosis","volume":"12","author":"Mehra","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1136\/ard-2024-225596_bib6","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1136\/ard-2023-224692","article-title":"Annals of the rheumatic diseases collection on autoantibodies in the rheumatic diseases: new insights into pathogenesis and the development of novel biomarkers","volume":"82","author":"Pisetsky","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225596_bib7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrrheum.2009.238","article-title":"Autoantibodies as predictive tools in systemic sclerosis","volume":"6","author":"Nihtyanova","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/ard-2024-225596_bib8","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1097\/CM9.0000000000001935","article-title":"Clinical correlations with disease-associated auto-antibodies in a Chinese cohort with systemic sclerosis","volume":"135","author":"Yang","year":"2022","journal-title":"Chin Med J (Engl)"},{"key":"10.1136\/ard-2024-225596_bib9","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1136\/annrheumdis-2021-222088","article-title":"Induced antibodies directed to the angiotensin receptor type 1 provoke skin and lung inflammation, dermal fibrosis and act species overarching","volume":"81","author":"Yue","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225596_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/art.42667","article-title":"Anti-Gephyrin antibodies: a novel specificity in patients with systemic sclerosis and lower bowel dysfunction","volume":"76","author":"McMahan","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2024-225596_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109740","article-title":"Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis","volume":"255","author":"Favoino","year":"2023","journal-title":"Clin Immunol"},{"key":"10.1136\/ard-2024-225596_bib12","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa052955","article-title":"Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis","volume":"354","author":"Baroni","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1136\/ard-2024-225596_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X221109404","article-title":"A broad look into the future of systemic sclerosis","volume":"14","author":"Riemekasten","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1136\/ard-2024-225596_bib14","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/rheumatology\/kex458","article-title":"Presence of anti-eukaryotic initiation factor-2B, anti-Ruvbl1\/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis","volume":"57","author":"Pauling","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard-2024-225596_bib15","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1136\/ard-2023-224184","article-title":"Single-cell analysis reveals key differences between early-stage and late-stage systemic sclerosis skin across autoantibody subgroups","volume":"82","author":"Clark","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225596_bib16","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s12026-023-09362-8","article-title":"Human antibody profiling technologies for autoimmune disease","volume":"71","author":"Carlton","year":"2023","journal-title":"Immunol Res"},{"key":"10.1136\/ard-2024-225596_bib17","doi-asserted-by":"crossref","first-page":"10958","DOI":"10.1021\/acs.analchem.8b02513","article-title":"High-throughput chip assay for investigating escherichia coli interaction with the blood-brain barrier using microbial and human proteome microarrays (dual-microarray technology)","volume":"90","author":"Feng","year":"2018","journal-title":"Anal Chem"},{"key":"10.1136\/ard-2024-225596_bib18","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.nbt.2015.09.002","article-title":"Exploration of high-density protein microarrays for antibody validation and autoimmunity profiling","volume":"33","author":"Sj\u00f6berg","year":"2016","journal-title":"N Biotechnol"},{"key":"10.1136\/ard-2024-225596_bib19","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1126\/science.abn1034","article-title":"Decoding the autoantibody reactome","volume":"383","author":"Jaycox","year":"2024","journal-title":"Science"},{"key":"10.1136\/ard-2024-225596_bib20","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/ard-2022-222686","article-title":"Mass spectrometry-based identification of new anti-LY and known antisynthetase autoantibodies","volume":"82","author":"Vulsteke","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225596_bib21","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.kint.2023.01.001","article-title":"Discovery of seven novel putative antigens in membranous nephropathy and membranous lupus nephritis identified by mass spectrometry","volume":"103","author":"Caza","year":"2023","journal-title":"Kidney Int"},{"key":"10.1136\/ard-2024-225596_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3171","article-title":"Genome-scale proteome quantification by DEEP SEQ mass spectrometry","volume":"4","author":"Zhou","year":"2013","journal-title":"Nat Commun"},{"key":"10.1136\/ard-2024-225596_bib23","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1002\/art.30539","article-title":"Immunization with DNA topoisomerase i and freund's complete adjuvant induces skin and lung fibrosis and autoimmunity via interleukin-6 signaling","volume":"63","author":"Yoshizaki","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2024-225596_bib24","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.it.2020.08.007","article-title":"Protein arginine methyltransferase 5 in T lymphocyte biology","volume":"41","author":"Sengupta","year":"2020","journal-title":"Trends Immunol"},{"key":"10.1136\/ard-2024-225596_bib25","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1172\/JCI131254","article-title":"Protein arginine methyltransferase 5 promotes cholesterol biosynthesis-mediated Th17 responses and autoimmunity","volume":"130","author":"Webb","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1136\/ard-2024-225596_bib26","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1074\/mcp.M111.015529","article-title":"Identification of new autoantigens for primary biliary cirrhosis using human proteome microarrays","volume":"11","author":"Hu","year":"2012","journal-title":"Mol Cell Proteomics"},{"key":"10.1136\/ard-2024-225596_bib27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.exer.2016.12.006","article-title":"Retinal pigment epithelium and microglia express the Cd5 antigen-like protein, a novel autoantigen in age-related macular degeneration","volume":"155","author":"Iannaccone","year":"2017","journal-title":"Exp Eye Res"},{"key":"10.1136\/ard-2024-225596_bib28","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.cell.2015.10.068","article-title":"Cd5L\/AIM regulates lipid biosynthesis and restrains Th17 cell pathogenicity","volume":"163","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.1136\/ard-2024-225596_bib29","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1038\/emi.2017.79","article-title":"Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III","volume":"6","author":"Wu","year":"2017","journal-title":"Emerg Microbes Infect"},{"key":"10.1136\/ard-2024-225596_bib30","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1164\/rccm.202103-0714OC","article-title":"Long-term safety and efficacy of tocilizumab in early systemic sclerosis-interstitial lung disease: open-label extension of a phase 3 randomized controlled trial","volume":"205","author":"Khanna","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1136\/ard-2024-225596_bib31","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.autrev.2017.05.024","article-title":"The role of endothelial cells in the vasculopathy of systemic sclerosis: a systematic review","volume":"16","author":"Mostmans","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1136\/ard-2024-225596_bib32","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1172\/JCI131700","article-title":"Cytotoxic Cd4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis","volume":"130","author":"Maehara","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1136\/ard-2024-225596_bib33","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.rdc.2023.01.014","article-title":"The exciting future for scleroderma: what therapeutic pathways are on the horizon","volume":"49","author":"Distler","year":"2023","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1136\/ard-2024-225596_bib34","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1002\/eji.1830250723","article-title":"A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2B mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells","volume":"25","author":"Mendel","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1136\/ard-2024-225596_bib35","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1136\/annrheumdis-2021-220043","article-title":"Preclinical models of arthritis for studying immunotherapy and immune tolerance","volume":"80","author":"Meehan","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225596_bib36","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/ard-2022-223633","article-title":"Pathogenic antibody response to glucose-6-phosphate isomerase targets a modified EPITOPE uniquely exposed on joint cartilage","volume":"82","author":"Li","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-225596_bib37","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1164\/rccm.2104003","article-title":"Partitioning of alveolar and conducting airway nitric oxide in scleroderma lung disease","volume":"165","author":"Girgis","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1136\/ard-2024-225596_bib38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1183\/09031936.00129806","article-title":"Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide","volume":"30","author":"Tiev","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1136\/ard-2024-225596_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1136\/ard-2024-225596_bib40","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131099","article-title":"Prmt5 regulates T cell interferon response and is a target for acute graft-versus-host disease","volume":"5","author":"Snyder","year":"2020","journal-title":"JCI Insight"},{"key":"10.1136\/ard-2024-225596_bib41","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.4049\/jimmunol.2100994","article-title":"Prmt5 in T cells drives Th17 responses, mixed granulocytic inflammation, and severe allergic airway inflammation","volume":"208","author":"Lewis","year":"2022","journal-title":"J Immunol"},{"key":"10.1136\/ard-2024-225596_bib42","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12974-023-02854-2","article-title":"Prmt5 deficiency inhibits Cd4+ T-cell Klf2\/S1Pr1 expression and ameliorates EAE disease","volume":"20","author":"Zheng","year":"2023","journal-title":"J Neuroinflammation"},{"key":"10.1136\/ard-2024-225596_bib43","doi-asserted-by":"crossref","first-page":"F375","DOI":"10.1152\/ajprenal.00487.2019","article-title":"Protein arginine methyltransferase 1 mediates renal fibroblast activation and fibrogenesis through activation of Smad3 signaling","volume":"318","author":"Zhu","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1136\/ard-2024-225596_bib44","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1016\/j.bbadis.2015.09.008","article-title":"Elevated protein arginine methyltransferase 1 expression regulates fibroblast motility in pulmonary fibrosis","volume":"1852","author":"Zakrzewicz","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1136\/ard-2024-225596_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-46711-z","article-title":"Fibroblast-specific Prmt5 deficiency suppresses cardiac fibrosis and left ventricular dysfunction in male mice","volume":"15","author":"Katanasaka","year":"2024","journal-title":"Nat Commun"},{"key":"10.1136\/ard-2024-225596_bib46","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41401-022-00963-x","article-title":"Adriamycin induces cardiac fibrosis in mice via Prmt5-mediated cardiac fibroblast activation","volume":"44","author":"Dong","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"10.1136\/ard-2024-225596_bib47","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202200238R","article-title":"Inhibition of protein arginine methyltransferase 1 alleviates liver fibrosis by attenuating the activation of hepatic stellate cells in mice","volume":"36","author":"Yan","year":"2022","journal-title":"FASEB J"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724000062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724000062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard-2024-225596","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T03:18:48Z","timestamp":1739503128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724000062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0003496724000062"],"URL":"https:\/\/doi.org\/10.1136\/ard-2024-225596","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and validation of anti-protein arginine methyltransferase 5 (PRMT5) antibody as a novel biomarker for systemic sclerosis (SSc)","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard-2024-225596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}